IFNGR1 Gene

Last updated on: 11.04.2022

Dieser Artikel auf Deutsch

Requires free registration (medical professionals only)

Please login to access all articles, images, and functions.

Our content is available exclusively to medical professionals. If you have already registered, please login. If you haven't, you can register for free (medical professionals only).


Requires free registration (medical professionals only)

Please complete your registration to access all articles and images.

To gain access, you must complete your registration. You either haven't confirmed your e-mail address or we still need proof that you are a member of the medical profession.

Finish your registration now

DefinitionThis section has been translated automatically.

The IFNGR1 gene (IFNGR1 stands for "Interferon Gamma Receptor 1") is a protein coding gene located at chromosome 6q23.3.

The IFNGR1 gene encodes the ligand-binding chain (alpha) of the gamma interferon receptor. The human interferon-gamma receptor is a heterodimer composed of the proteins IFNGR1 and the accessory transmembrane factor IFNGR2. When assembled, both proteins form a functional receptor.

General informationThis section has been translated automatically.

The receptor subunit for interferon-gamma, plays a critical role in antimicrobial, antiviral and antitumor responses by activating effector immune cells and enhancing antigen presentation. Upon ligand binding, the intracellular domain of IFNGR1 opens and allows association of the downstream signaling components JAK1 and JAK2. Activated JAK1 in turn phosphorylates IFNGR1 to form a docking site for STAT1. Subsequent phosphorylation of STAT1 leads to dimerization, translocation to the nucleus, and stimulation of transcription of target genes. STAT3 can also be activated in a similar manner, although the activation appears to be weaker. Phosphorylation of the intracellular domain of IFNGR1 also provides a docking site for SOCS1, which regulates the JAK-STAT pathway by competing with STAT1 binding to IFNGR1.

Clinical pictureThis section has been translated automatically.

Genetic variation in IFNGR1 is associated with susceptibility to Helicobacter pylori infection as well as systemic Listeria monocytogenes (Eshleman EM et al. 2017). In addition, defects in IFNGR1 are one of the causes of "Mendelian Susceptibility to Mycobacterial Diseases" (also referred to as "familial disseminated atypical mycobacterial infection").

LiteratureThis section has been translated automatically.

  1. Canedo P et al (2008) The interferon gamma receptor 1 (IFNGR1) -56C/T gene polymorphism is associated with increased risk of early gastric carcinoma. Gut 57:1504-1508.
  2. Eshleman EM et al (2017) Down regulation of macrophage IFNGR1 exacerbates systemic L. monocytogenes infection. PLoS Pathog 13:e1006388.
  3. van de Vosse E et al. (2017) IFN-γR1 defects: Mutation update and description of the IFNGR1 variation database. Hum Mutat 38:1286-1296

Last updated on: 11.04.2022